| Filed | Form | Description | |
|---|---|---|---|
| 4/30/24 | DEFA14A | DEFA14A | → |
| 4/19/24 | DEF 14A | DEF 14A | → |
| 6/5/23 | DEFA14A | DEFA14A | → |
| 4/28/23 | DEFA14A | DEFA14A | → |
| 4/28/23 | DEF 14A | DEF 14A | → |
| 4/27/22 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 6/27/25 | 4 | 4 | → |
| 6/27/25 | 4 | 4 | → |
| 6/27/25 | 4 | 4 | → |
| 6/27/25 | 4 | 4 | → |
| 6/27/25 | 4 | 4 | → |
| 6/27/25 | 4 | 4 | → |
| ↓ | |||
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases.